44-302 : Special Drug Use-Results Survey of VELEXBRU (WM/LPL)
Not Applicable
- Conditions
- Waldenstrom macroglobulinemia (WM) and lymphoplasmacytic lymphoma (LPL)
- Registration Number
- JPRN-jRCT2011210005
- Lead Sponsor
- Kuro Toshihiko
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
All patients with WM/LPL for whom VELEXBLU is administered
Exclusion Criteria
patients who have not received VELEXB
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method